<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CU Cancer Center Associate Director Highlights Key Studies at 2025 ASCO GI Cancer Symposium

by DocWire News | January 24, 2025
placeholder

Christopher Lieu, MD, Associate Director of Clinical Research at the University of Colorado Cancer Center, discusses three pivotal abstracts presented at the 2025 ASCO GI Cancer Symposium. These emerging studies, including Checkmate 9DW, Breakwater, and Checkmate 8HW, showcase advancements in immunotherapy and targeted treatments for liver and colorectal cancers.

Topics: Press Coverage